Keros Therapeutics · 5 months ago
Join our Talent Community
Keros is dedicated to delivering significant clinical benefits to patients with disorders linked to dysfunctional TGF-β signaling. They are focused on developing differentiated product candidates aimed at targeting critical pathways for the growth and maintenance of various tissues. This job posting invites candidates to join their talent community for future opportunities.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Qualification
Company
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Funding
Current Stage
Public CompanyTotal Funding
$379.5MKey Investors
Pontifax
2024-01-03Post Ipo Equity· $140M
2020-11-13Post Ipo Equity· $149.5M
2020-04-07IPO
Recent News
Keros Therapeutics, Inc.
2025-11-21
2025-11-20
Keros Therapeutics, Inc.
2025-11-19
Company data provided by crunchbase